Immix Biopharma, Inc. (IMMX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $732.9K | -37.8% |
| 2024 | $1.18M | +2160.9% |
| 2023 | $52.1K | — |
| 2021 | $802 | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $732.9K | -37.8% |
| 2024 | $1.18M | +2160.9% |
| 2023 | $52.1K | — |
| 2021 | $802 | — |